MaltSci 麦伴科研

Appearance

Popular Reports / aging-biology

This report is written by MaltSci based on the latest literature and research findings

How does age-related inflammation contribute to disease? ​

Abstract ​

The global demographic shift towards an aging population has brought significant attention to the health challenges associated with advanced age, particularly the rise in age-related diseases. This review explores the concept of 'inflammaging,' a chronic, low-grade inflammatory state that develops progressively with age and is increasingly recognized as a pivotal contributor to various age-associated conditions, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. The mechanisms driving inflammaging are multifaceted, involving alterations in immune system function, the accumulation of senescent cells, and changes in the gut microbiome. These biological processes contribute to the pathogenesis of specific diseases and highlight potential lifestyle and pharmacological interventions to mitigate the adverse effects of inflammation in aging populations. The review examines the impact of age-related inflammation on cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes, emphasizing the role of chronic inflammation in exacerbating these conditions. Furthermore, it discusses potential interventions, including lifestyle modifications and pharmacological approaches, to combat the effects of inflammaging. Understanding the relationship between age-related inflammation and disease is crucial for developing effective strategies to improve health outcomes in the aging population and alleviate the growing burden of age-related diseases on healthcare systems.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Biological Mechanisms of Age-Related Inflammation
    • 2.1 Immune System Changes with Age
    • 2.2 Role of Senescent Cells
    • 2.3 Gut Microbiome Alterations
  • 3 Impact of Age-Related Inflammation on Specific Diseases
    • 3.1 Cardiovascular Diseases
    • 3.2 Neurodegenerative Disorders
    • 3.3 Metabolic Syndromes
  • 4 Potential Interventions to Mitigate Inflammaging
    • 4.1 Lifestyle Modifications
    • 4.2 Pharmacological Approaches
    • 4.3 Future Directions in Research
  • 5 Public Health Implications
    • 5.1 Economic Burden of Age-Related Diseases
    • 5.2 Strategies for Healthy Aging
  • 6 Conclusion

1 Introduction ​

The global demographic shift towards an aging population has brought significant attention to the health challenges associated with advanced age, particularly the rise in age-related diseases. This phenomenon, often termed "inflammaging," refers to a chronic, low-grade inflammatory state that develops progressively with age and is increasingly recognized as a pivotal contributor to various age-associated conditions, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes [1][2]. As life expectancy continues to increase, the prevalence and severity of these diseases are projected to escalate, thereby straining healthcare systems and impacting the quality of life for older adults [1].

The significance of understanding age-related inflammation lies not only in its implications for individual health but also for public health at large. Chronic inflammation has been implicated as a common pathological mechanism underlying many age-related diseases, making it a critical target for therapeutic intervention [3]. Moreover, the interplay between inflammation and aging presents an opportunity to identify novel strategies for promoting healthy aging and reducing the burden of disease in the elderly [2][4].

Current research indicates that the mechanisms driving inflammaging are multifaceted and complex, involving alterations in immune system function, the accumulation of senescent cells, and changes in the gut microbiome [2][5]. These biological processes not only contribute to the pathogenesis of specific diseases but also highlight the potential for lifestyle and pharmacological interventions to mitigate the adverse effects of inflammation in aging populations [5][6].

This review aims to synthesize the current understanding of how age-related inflammation influences disease pathogenesis. The following sections will explore the biological mechanisms underlying inflammaging, including changes in immune system function, the role of senescent cells, and alterations in the gut microbiome. We will also examine the impact of age-related inflammation on specific diseases, such as cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. Additionally, we will discuss potential interventions to mitigate the effects of inflammaging, encompassing lifestyle modifications and pharmacological approaches. Finally, the public health implications of these findings will be addressed, emphasizing the economic burden of age-related diseases and strategies for promoting healthy aging.

By elucidating the relationship between age-related inflammation and disease, this review seeks to provide a comprehensive overview of the current landscape of research and highlight the importance of targeting inflammation as a means to improve health outcomes in the aging population. Understanding these connections is crucial for developing effective strategies to enhance the quality of life for older adults and alleviate the growing burden of age-related diseases on healthcare systems.

2 Biological Mechanisms of Age-Related Inflammation ​

2.1 Immune System Changes with Age ​

Age-related inflammation, commonly referred to as "inflammaging," is a significant contributor to the pathogenesis of various chronic diseases associated with aging. This phenomenon is characterized by a chronic, low-grade inflammatory state that arises due to multiple biological mechanisms and systemic changes in the immune system as individuals age.

One of the primary mechanisms underlying inflammaging is the phenomenon of immunosenescence, which refers to the gradual deterioration of the immune system associated with aging. This deterioration results in diminished efficiency and fidelity of immune responses, leading to a state of chronic inflammation even in the absence of acute infection or injury. Specifically, elderly individuals often exhibit increased levels of circulating pro-inflammatory cytokines such as tumor necrosis factor (TNF), interleukin (IL)-1β, and IL-6, which are associated with heightened inflammatory responses. These cytokines not only reflect an altered immune profile but also actively contribute to the progression of age-related diseases, including cardiovascular disease, diabetes, and neurodegenerative disorders [3][7][8].

Additionally, the accumulation of cellular debris and the presence of senescent cells in tissues can exacerbate inflammation. Cellular senescence, a state in which cells cease to divide and function, is often accompanied by a senescence-associated secretory phenotype (SASP) that releases inflammatory mediators, further perpetuating the inflammatory cycle. This creates a feedback loop where inflammation contributes to further cellular damage and senescence, ultimately leading to the development of age-related pathologies [9][10].

Moreover, the role of macrophages, a key component of the immune system, becomes increasingly significant in the context of aging. In older adults, macrophages exhibit altered functions, including a heightened pro-inflammatory response and impaired resolution of inflammation. These changes can lead to chronic inflammatory states that are implicated in the pathogenesis of various age-related diseases. For instance, the role of macrophages in tissue repair and their involvement in cancer progression underscores their dual role in promoting inflammation and mediating tissue damage [7][8].

The interplay between chronic inflammation and metabolic dysregulation, often termed metaflammation, is another crucial aspect of age-related diseases. Metaflammation arises from nutrient excess and is characterized by similar mechanisms as those seen in inflammaging. The gut microbiota also plays a central role in both conditions, influencing inflammatory pathways and metabolic processes that are critical for maintaining health in older adults [4][11].

Overall, the biological mechanisms driving age-related inflammation involve complex interactions between immune system changes, cellular senescence, metabolic dysregulation, and the microenvironment. These processes not only contribute to the onset and progression of chronic diseases but also highlight potential therapeutic targets for mitigating the adverse effects of aging and improving health outcomes in the elderly [6][12].

2.2 Role of Senescent Cells ​

Age-related inflammation, often referred to as "inflammaging," plays a significant role in the development and progression of various chronic diseases. This chronic, low-grade inflammation is primarily driven by the accumulation of senescent cells, which are characterized by a permanent cessation of cell division and the secretion of pro-inflammatory factors, collectively known as the senescence-associated secretory phenotype (SASP).

Senescent cells accumulate in tissues as individuals age, contributing to a state of chronic inflammation that exacerbates the risk of numerous age-related diseases, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. The presence of these senescent cells is not merely a passive occurrence; rather, they actively secrete a range of pro-inflammatory cytokines, chemokines, and other mediators that can alter tissue homeostasis and promote a pro-inflammatory environment [13][14][15].

One critical aspect of senescent cells is their ability to drive chronic inflammation through the SASP. The SASP includes various factors that can influence neighboring cells, leading to a cascade of inflammatory responses. This phenomenon contributes to tissue dysfunction and is implicated in the pathogenesis of chronic diseases. For instance, in cardiovascular diseases, senescent T cells have been shown to produce large quantities of pro-inflammatory cytokines, which can exacerbate conditions such as hypertension and atherosclerosis [16].

Moreover, the senescence-associated inflammation is thought to create a microenvironment conducive to tumor development. Senescent cells can enhance local inflammation, which may promote the growth and survival of nearby cancer cells, thus linking cellular senescence to cancer progression [17]. The accumulation of senescent cells also leads to the deregulation of immune function, further impairing the body's ability to respond to infections and contributing to the increased susceptibility to infectious diseases in the elderly [18][19].

The interplay between senescent cells and the immune system is particularly noteworthy. As the immune system ages, a phenomenon known as immunosenescence occurs, characterized by a decline in the function of immune cells, including natural killer (NK) cells and T cells. This decline impairs the clearance of senescent cells, leading to their accumulation and the perpetuation of the inflammatory state [20][21]. Consequently, the aging immune system is less effective at combating both chronic inflammation and infections, further compounding health issues in older adults [21].

In summary, age-related inflammation, primarily driven by the accumulation of senescent cells and their associated secretory phenotype, contributes significantly to the pathogenesis of various chronic diseases. The persistent inflammatory state disrupts tissue homeostasis, promotes disease progression, and impairs immune responses, underscoring the importance of targeting senescent cells as a potential therapeutic strategy for mitigating age-related diseases [16][17][18].

2.3 Gut Microbiome Alterations ​

Age-related inflammation, often referred to as "inflammaging," is a chronic low-grade inflammatory state that develops as individuals age and is associated with a variety of age-related diseases. This phenomenon is closely linked to alterations in the gut microbiome, which plays a critical role in modulating immune responses and maintaining homeostasis within the body.

As individuals age, significant changes occur in the gut microbiota composition, leading to dysbiosis characterized by a decrease in beneficial commensal bacteria and an increase in pro-inflammatory microbial species. These alterations can contribute to a heightened inflammatory response, impacting the host's immune system and overall health. For instance, studies have demonstrated that aging is associated with an increase in proteolytic bacteria and a decrease in saccharolytic bacteria, which are essential for maintaining gut health and preventing inflammation [22]. Such shifts in microbial diversity can lead to increased intestinal permeability, often termed "leaky gut," allowing microbial products and toxins to enter the bloodstream, thereby exacerbating systemic inflammation [23].

Furthermore, the dysbiosis observed in older adults has been linked to various age-related diseases, including sarcopenia, neurodegenerative disorders, and metabolic syndromes. For example, imbalances in gut microbiota have been implicated in the pathogenesis of sarcopenia, where the chronic inflammatory milieu can adversely affect muscle physiology [24]. Additionally, the gut microbiome's composition influences the production of metabolites that can either promote health or contribute to disease; a decline in beneficial short-chain fatty acids (SCFAs) production due to dysbiosis may lead to inflammation and metabolic dysfunction [25].

The relationship between gut microbiota and age-related inflammation is complex and bidirectional. On one hand, the gut microbiome can influence immune senescence and the inflammatory state of the host; on the other hand, age-related inflammation can further alter the gut microbiome, creating a vicious cycle. Research has shown that inflammatory markers are positively correlated with specific bacterial taxa associated with dysbiosis, while beneficial taxa often correlate with lower levels of inflammation [26].

Moreover, interventions targeting the gut microbiome, such as dietary modifications, prebiotics, and probiotics, have shown promise in modulating inflammation and potentially mitigating age-related diseases. These strategies aim to restore a healthy microbiota composition, enhance immune function, and reduce chronic inflammation, thereby promoting healthy aging [27].

In conclusion, age-related inflammation significantly contributes to the pathogenesis of various diseases through its interplay with gut microbiome alterations. The dysbiotic state of the gut microbiota in older adults not only exacerbates inflammatory responses but also serves as a potential therapeutic target for interventions aimed at enhancing healthspan and longevity. Understanding these biological mechanisms provides valuable insights into the complex relationship between aging, inflammation, and gut health, highlighting the importance of maintaining a balanced microbiome for overall well-being in the elderly population.

3 Impact of Age-Related Inflammation on Specific Diseases ​

3.1 Cardiovascular Diseases ​

Age-related inflammation, often referred to as "inflammaging," plays a significant role in the development and progression of cardiovascular diseases (CVDs). This chronic low-grade inflammation is characterized by the persistent presence of pro-inflammatory cytokines, chemokines, and other mediators, which contribute to various pathological processes associated with aging.

One of the primary mechanisms through which inflammaging influences cardiovascular health is by promoting atherosclerosis. The state of chronic inflammation leads to the activation of leukocytes, endothelial cells, and vascular smooth muscle cells, which accelerates vascular aging and the development of atherosclerotic plaques. Inflammaging also enhances platelet reactivity, increasing the risk of thrombotic events such as plaque rupture and erosion, which can result in acute cardiovascular complications [28].

Research has demonstrated that the inflammatory burden is modulated by age, with systemic inflammation markers like C-reactive protein (CRP) and serum amyloid A (SAA) showing significant positive associations with age. In contrast, vascular inflammation markers such as pentraxin-3 (PTX-3) and soluble vascular cell adhesion molecule-1 (sVCAM) tend to decrease with age. This duality suggests that while systemic inflammation increases, the vascular inflammatory response may exhibit a regulatory pattern that complicates the interpretation of vascular health in older individuals [29].

The implications of inflammaging extend beyond atherosclerosis. Elevated levels of inflammatory mediators associated with aging are linked to other cardiovascular conditions, including heart failure with preserved ejection fraction (HFpEF) and hypertension. These conditions often coexist with other age-related disorders, underscoring the multifactorial nature of cardiovascular risks in the elderly [30]. The role of epicardial adipose tissue (EAT), which accumulates with age and contributes to local inflammation, further exacerbates cardiovascular risks by secreting pro-inflammatory substances that negatively affect cardiac structure and function [31].

Moreover, the impact of psychological factors on inflammation cannot be overlooked. Studies have shown that negative self-perceptions of aging correlate with increased levels of CRP, indicating that psychological aspects of aging can influence cardiovascular health through inflammatory pathways [32].

In summary, age-related inflammation significantly contributes to cardiovascular diseases through mechanisms involving the promotion of atherosclerosis, alteration of vascular responses, and interaction with psychological factors. Understanding these processes is crucial for developing targeted therapeutic strategies aimed at mitigating the effects of inflammaging and improving cardiovascular health in the aging population [33][34].

3.2 Neurodegenerative Disorders ​

Age-related inflammation, often referred to as "inflammaging," significantly contributes to the pathogenesis of neurodegenerative disorders, which include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Neuroinflammation is characterized by the activation of glial cells, particularly microglia and astrocytes, and the subsequent release of pro-inflammatory mediators and reactive oxygen species. This chronic inflammatory state is exacerbated with aging and plays a crucial role in neuronal damage and cognitive decline.

The process of neuroinflammation involves several key mechanisms. For instance, aging leads to a shift in the phenotypes of microglia and astrocytes towards a more active "pro-inflammatory" state, resulting in chronic low-grade neuroinflammation. This state is associated with increased production of inflammatory cytokines, which can further damage neurons and contribute to the progression of neurodegenerative diseases (Alsegiani and Shah 2020) [35].

Research indicates that neuroinflammation is a common feature in various neurodegenerative diseases. In the context of Alzheimer's disease, neuroinflammation has been implicated in the development and progression of the disease, as activated microglia respond to amyloid-beta deposits, contributing to neuronal damage and cognitive decline (Piazza and Lynch 2009) [36]. Moreover, chronic inflammation can also exacerbate the effects of other stressors, leading to enhanced neurodegenerative processes (Piazza and Lynch 2009) [36].

In animal models, chronic neuroinflammation has been shown to lead to memory deficits and cognitive decline. For example, studies involving mice with genetically enhanced NF-κB activity demonstrated that chronic inflammation is linked to an early onset of memory loss and increased neuroinflammation (Fielder et al. 2020) [37]. This indicates that inflammation not only contributes to the progression of neurodegenerative diseases but may also be a causal factor in cognitive decline associated with aging.

Furthermore, the role of inflammation in neurodegenerative diseases is compounded by the phenomenon of immunosenescence, which refers to the age-related decline in immune function. This decline can lead to an increased inflammatory response, thereby enhancing the risk of neurodegenerative conditions (Costantini et al. 2018) [38]. The interplay between systemic inflammation and neuroinflammation suggests that peripheral inflammatory processes can significantly influence brain function and contribute to the development of neurological disorders (Moyse et al. 2022) [39].

Additionally, neuroinflammation has been linked to the failure of normal age-related neuroprotective processes. While inflammation can promote regenerative processes in response to injury, chronic neuroinflammation may disrupt these processes, leading to neuronal death and the progression of neurodegenerative diseases (Mayne et al. 2020) [40].

In conclusion, age-related inflammation plays a pivotal role in the pathogenesis of neurodegenerative disorders. Chronic neuroinflammation, driven by the activation of immune cells and the release of inflammatory mediators, contributes to neuronal damage and cognitive decline. Understanding the mechanisms underlying neuroinflammation and its relationship with aging is crucial for developing effective therapeutic strategies to mitigate the impact of neurodegenerative diseases. Further research is needed to explore potential interventions that could target neuroinflammatory pathways to promote brain health in the aging population.

3.3 Metabolic Syndromes ​

Age-related inflammation, often referred to as "inflammaging," plays a significant role in the pathogenesis of various metabolic syndromes and related diseases. This chronic, low-grade inflammation is characterized by an increased presence of inflammatory markers and immune cell activation, which together contribute to the development and progression of metabolic disorders, including obesity, insulin resistance, and type 2 diabetes (T2D).

The aging process is associated with a notable increase in chronic inflammation, which is primarily driven by changes in immune system function and alterations in adipose tissue metabolism. Age-related immunosenescence leads to an increase in pro-inflammatory cytokines and a decline in the immune system's efficiency, creating a chronic inflammatory environment. This state of chronic inflammation has been linked to the dysfunction of various tissues, including adipose tissue, which is now recognized as an active endocrine organ that secretes inflammatory mediators [41].

In the context of metabolic syndrome, age-related inflammation manifests through several mechanisms. For instance, visceral adiposity, which tends to increase with age, is associated with aberrant adipogenesis and altered adipokine secretion. This change can lead to insulin resistance and lipotoxicity, further exacerbating metabolic dysfunction [42]. The inflammatory response within adipose tissue includes the activation of macrophages and the secretion of inflammatory factors, creating a feedback loop that perpetuates tissue inflammation and metabolic disturbances [42][43].

Moreover, the interplay between gut microbiota and inflammation is crucial. The gut microbiome influences systemic inflammation and metabolic health, with dysbiosis potentially contributing to the inflammatory state seen in aging individuals. Chronic exposure to inflammatory stimuli from the gut can exacerbate low-grade inflammation in metabolic tissues, including the liver and adipose tissue, thus playing a pivotal role in the development of metabolic syndromes [44].

The impact of this age-related inflammation is profound. It not only contributes to the onset of metabolic syndrome but also accelerates the progression of associated complications, such as cardiovascular diseases and type 2 diabetes. Inflammaging creates a scenario where the metabolic system is under constant stress, leading to a decline in insulin sensitivity and an increased risk of metabolic disorders [4].

In summary, age-related inflammation significantly contributes to metabolic syndromes through mechanisms involving chronic low-grade inflammation, immune dysregulation, and the interplay between metabolic and inflammatory pathways. Understanding these connections highlights the importance of targeting inflammation as a therapeutic strategy to mitigate the risks associated with aging and metabolic diseases.

4 Potential Interventions to Mitigate Inflammaging ​

4.1 Lifestyle Modifications ​

Age-related inflammation, often referred to as "inflammaging," is characterized by a chronic, low-grade inflammatory state that develops with advancing age. This condition is a significant contributor to the pathogenesis of various age-related diseases, including cardiovascular disease, diabetes, neurodegenerative disorders, and cancer. Inflammaging results from a combination of factors, including immune system dysregulation, metabolic changes, and environmental stressors, leading to an increased production of pro-inflammatory cytokines and markers such as TNF-α, IL-6, and C-reactive protein[45][46].

The mechanisms by which inflammaging contributes to disease are multifaceted. Chronic inflammation can lead to tissue damage, impaired immune responses, and alterations in metabolic homeostasis. For instance, increased levels of pro-inflammatory cytokines can exacerbate the progression of conditions like sarcopenia and frailty, and they have been linked to higher risks of morbidity and mortality in older adults[4][6]. Additionally, inflammaging has been associated with the dysregulation of the immune system, termed immunosenescence, which diminishes the body's ability to respond effectively to infections and vaccinations[2][45].

To mitigate the effects of inflammaging and its associated diseases, various interventions can be employed. Lifestyle modifications are particularly promising. These may include dietary changes, physical activity, and the management of stress, all of which can significantly influence inflammatory processes. Nutritional interventions, such as the inclusion of omega-3 fatty acids, probiotics, and antioxidants, have shown potential in reducing markers of inflammation and improving overall health outcomes in older adults[11][47].

Regular physical activity is another critical lifestyle modification that can combat inflammaging. Exercise has been demonstrated to lower levels of systemic inflammation and enhance immune function, contributing to improved health and longevity[6]. Furthermore, maintaining a healthy weight through balanced nutrition and regular physical activity can reduce the inflammatory burden associated with obesity and metabolic syndrome[4].

In addition to dietary and exercise strategies, emerging research suggests that targeting specific inflammatory pathways may provide therapeutic benefits. For instance, interventions that modulate the activity of inflammasomes, which play a key role in the inflammatory response, could offer new avenues for reducing age-related inflammation and improving health outcomes[48].

Overall, addressing inflammaging through lifestyle modifications and targeted interventions holds significant promise for enhancing healthspan and reducing the incidence of age-related diseases. Continued research into the mechanisms of inflammation and effective strategies for its modulation will be essential in developing comprehensive approaches to healthy aging.

4.2 Pharmacological Approaches ​

Age-related inflammation, commonly referred to as "inflammaging," is characterized by a chronic, low-grade inflammatory state that emerges with aging. This condition is associated with an increased risk of various chronic diseases, including cardiovascular diseases, metabolic disorders, neurodegenerative diseases, and cancer. Inflammaging is driven by several factors, including immune system deterioration, mitochondrial dysfunction, dysbiosis, and the accumulation of damage-associated molecular patterns (DAMPs) [30].

The mechanisms underlying inflammaging involve the activation of innate immune pathways, particularly the NLRP3 inflammasome, which recognizes stress signals associated with aging and metabolic dysregulation [4]. This chronic inflammation contributes to the pathogenesis of age-related diseases by perpetuating a cycle of immune activation that leads to tissue damage, organ dysfunction, and increased morbidity [11]. For instance, elevated levels of pro-inflammatory cytokines such as IL-6 and TNF-α are common in elderly individuals and have been linked to frailty, cognitive decline, and cardiovascular risk [49].

To mitigate the adverse effects of inflammaging, various pharmacological approaches have been proposed. One strategy focuses on targeting pro-inflammatory cytokines through the use of biologics or small molecules that inhibit their signaling pathways. For example, agents that block IL-1 and IL-18 signaling have shown promise in preclinical studies [50]. Additionally, inhibitors of the NLRP3 inflammasome are being explored for their potential to reduce chronic inflammation and improve outcomes in age-related diseases [48].

Another pharmacological intervention involves the use of caloric restriction mimetics and compounds that activate pathways associated with cellular stress responses, such as the p38 mitogen-activated protein kinase inhibitors [11]. These approaches aim to enhance the body's resilience to stressors and reduce the inflammatory burden associated with aging.

Furthermore, senolytics, which are agents that selectively induce apoptosis in senescent cells, have emerged as a promising therapeutic strategy. By clearing these dysfunctional cells, senolytics can potentially reduce the overall inflammatory milieu and improve health outcomes in aging [11].

In summary, age-related inflammation significantly contributes to the onset and progression of chronic diseases through mechanisms that involve persistent immune activation and tissue damage. Pharmacological interventions targeting inflammatory pathways and cellular senescence hold potential for mitigating the effects of inflammaging and improving healthspan in the aging population.

4.3 Future Directions in Research ​

Aging is intricately linked to a chronic, low-grade inflammatory state known as "inflammaging," which significantly contributes to the pathogenesis of various age-related diseases. This phenomenon is characterized by elevated levels of pro-inflammatory cytokines, such as TNF-α and IL-6, alongside a decline in the efficiency of the immune system. As individuals age, their immune responses become dysregulated, leading to increased susceptibility to chronic diseases, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes [3][11][12].

The underlying mechanisms of inflammaging involve multiple factors, including cellular senescence, changes in the gut microbiota, and metabolic dysregulation. Cellular senescence contributes to a pro-inflammatory environment, as senescent cells secrete a variety of inflammatory mediators that exacerbate tissue damage and immune dysfunction [48][51]. Furthermore, dysbiosis in the gut microbiome has been shown to influence systemic inflammation, as certain microbial compositions can trigger inflammatory pathways that accelerate aging [4][52].

To mitigate the effects of inflammaging, various interventions have been proposed. Non-pharmacological strategies, such as dietary modifications, physical activity, and nutraceutical supplements, have shown promise in restoring immune homeostasis and reducing chronic inflammation [11][52]. For instance, dietary components like polyphenols found in extra-virgin olive oil have been identified as potential modulators of inflammation and autophagy, thereby promoting healthy aging [52]. Pharmacological approaches, including caloric restriction mimetics and senolytics, aim to target the underlying mechanisms of inflammation directly, offering potential pathways to enhance healthspan and reduce the incidence of age-related diseases [11][51].

Future research directions should focus on understanding the individual variability in inflammaging, as it is shaped by genetic, lifestyle, and environmental factors [53]. The development of inflammatory clocks that quantify an individual's inflammatory status may provide valuable insights into personalized interventions [53]. Additionally, further exploration of the role of inflammasomes in aging could unveil new therapeutic targets, as these immune complexes are central to the recognition of age-related stressors and inflammation [48][54].

In summary, the interplay between age-related inflammation and disease underscores the importance of targeted interventions to promote healthy aging. Continued research into the mechanisms of inflammaging and the development of personalized strategies will be crucial in addressing the challenges posed by an aging population and its associated health burdens.

5 Public Health Implications ​

5.1 Economic Burden of Age-Related Diseases ​

Age-related inflammation, commonly referred to as "inflammaging," is a significant factor in the pathogenesis of various chronic diseases prevalent in older populations. This chronic, low-grade inflammatory state is characterized by elevated levels of pro-inflammatory cytokines and contributes to the initiation and progression of diseases such as cardiovascular disease, diabetes, Alzheimer's disease, frailty, sarcopenia, osteoporosis, and cancer [8][12][55].

The underlying mechanisms of inflammaging involve a combination of factors, including cellular senescence, changes in the immune system (immunosenescence), and alterations in the tissue microenvironment. As individuals age, the immune system becomes less efficient, which not only impairs responses to new pathogens but also maintains a basal state of inflammation. This chronic inflammation can lead to increased oxidative stress and a breakdown of immune homeostasis, further exacerbating age-related health issues [3][8][56].

From a public health perspective, the implications of age-related inflammation are profound. The increasing life expectancy has not been matched by an increase in healthy life years, resulting in a growing burden of age-associated disorders. This burden places significant pressure on healthcare systems due to the rising prevalence of chronic diseases that require ongoing management and treatment [11][28].

The economic burden of age-related diseases linked to chronic inflammation is substantial. Chronic diseases often require extensive medical resources, including hospitalizations, long-term care, and medications, which can lead to increased healthcare costs for individuals and society. For instance, cardiovascular diseases and diabetes, both associated with chronic inflammation, are leading causes of morbidity and mortality, contributing significantly to healthcare expenditures [1][57].

Furthermore, the relationship between chronic inflammation and age-related diseases suggests that targeting inflammatory pathways may offer therapeutic opportunities to mitigate these conditions. Strategies such as dietary interventions, pharmacological treatments, and lifestyle modifications aimed at reducing inflammation could potentially enhance healthspan and reduce the incidence of chronic diseases [4][11].

In conclusion, age-related inflammation plays a critical role in the development of chronic diseases, posing significant public health challenges and economic burdens. Addressing this issue through targeted interventions could improve health outcomes for older adults and alleviate some of the financial strain on healthcare systems.

5.2 Strategies for Healthy Aging ​

Age-related inflammation, commonly referred to as "inflammaging," is a chronic, low-grade inflammatory state that emerges as individuals age. This phenomenon has been implicated in the development and progression of various age-related diseases, including cardiovascular diseases, neurodegenerative disorders, metabolic syndromes, and cancer. The underlying mechanisms of inflammaging involve an interplay of immune dysregulation, oxidative stress, and cellular senescence, which collectively contribute to the decline in physiological functions and the increased morbidity and mortality associated with aging.

Chronic inflammation is a significant driver of age-related diseases. For instance, elevated levels of pro-inflammatory cytokines such as IL-6 and TNF-α are often observed in older adults, leading to the activation of inflammatory pathways that exacerbate tissue damage and dysfunction. This persistent inflammatory state not only compromises the immune system's ability to respond to pathogens but also promotes the onset of chronic conditions such as type II diabetes, Alzheimer's disease, and cardiovascular disease [11][55][58].

The implications for public health are profound. As life expectancy increases, the burden of age-associated diseases continues to rise, necessitating effective strategies to mitigate the impact of chronic inflammation. The concept of healthy aging emphasizes the importance of maintaining physiological resilience and reducing the incidence of chronic diseases through various interventions. These interventions can be broadly categorized into pharmacological treatments, dietary modifications, and lifestyle changes.

Pharmacological approaches may include the use of anti-inflammatory agents and immunomodulators aimed at restoring immune homeostasis and reducing systemic inflammation. Non-pharmacological strategies, such as dietary interventions rich in antioxidants and anti-inflammatory compounds, physical activity, and nutraceutical supplements, have shown promise in alleviating the effects of inflammaging [6][12][59].

Moreover, lifestyle modifications that promote physical activity and a balanced diet can significantly influence the inflammatory milieu. Regular exercise has been shown to have anti-inflammatory effects, potentially counteracting the adverse consequences of chronic inflammation associated with aging [51][60].

In conclusion, addressing age-related inflammation through targeted interventions is crucial for promoting healthy aging and reducing the burden of chronic diseases. The exploration of innovative therapeutic strategies, combined with lifestyle modifications, presents a multifaceted approach to enhancing the health span of older adults, ultimately leading to improved quality of life and reduced healthcare costs associated with age-related diseases [6][11][12].

6 Conclusion ​

The review highlights the significant role of age-related inflammation, or 'inflammaging,' in the pathogenesis of various chronic diseases prevalent in older populations. The primary findings indicate that chronic low-grade inflammation is driven by complex biological mechanisms, including immune system changes, cellular senescence, and alterations in the gut microbiome. These mechanisms not only contribute to the development of cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes but also underscore the urgent need for effective therapeutic interventions. Current research shows that lifestyle modifications, such as dietary changes and physical activity, along with pharmacological approaches targeting inflammatory pathways, can mitigate the adverse effects of inflammaging. However, the intricate interplay between inflammation and aging necessitates a comprehensive understanding of individual variability and personalized strategies for intervention. Future research should focus on elucidating the specific pathways involved in inflammaging and developing targeted therapies to enhance healthspan and improve quality of life for older adults. Addressing the public health implications of age-related diseases linked to chronic inflammation is essential, as the economic burden on healthcare systems continues to grow. Therefore, promoting healthy aging through a combination of lifestyle and pharmacological interventions is critical for reducing the incidence of chronic diseases and enhancing the overall well-being of the aging population.

References ​

  • [1] Yuki Sato. Immune Aging and Its Implication for Age-Related Disease Progression.. Physiology (Bethesda, Md.)(IF=10.3). 2025. PMID:39887318. DOI: 10.1152/physiol.00051.2024.
  • [2] Amir Ajoolabady;Domenico Pratico;Daolin Tang;Shuqin Zhou;Claudio Franceschi;Jun Ren. Immunosenescence and inflammaging: Mechanisms and role in diseases.. Ageing research reviews(IF=12.4). 2024. PMID:39395575. DOI: 10.1016/j.arr.2024.102540.
  • [3] Claudio Franceschi;Judith Campisi. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.. The journals of gerontology. Series A, Biological sciences and medical sciences(IF=3.8). 2014. PMID:24833586. DOI: 10.1093/gerona/glu057.
  • [4] Claudio Franceschi;Paolo Garagnani;Paolo Parini;Cristina Giuliani;Aurelia Santoro. Inflammaging: a new immune-metabolic viewpoint for age-related diseases.. Nature reviews. Endocrinology(IF=40.0). 2018. PMID:30046148. DOI: 10.1038/s41574-018-0059-4.
  • [5] Paolo Di Giosia;Cosimo Andrea Stamerra;Paolo Giorgini;Tannaz Jamialahamdi;Alexandra E Butler;Amirhossein Sahebkar. The role of nutrition in inflammaging.. Ageing research reviews(IF=12.4). 2022. PMID:35219904. DOI: 10.1016/j.arr.2022.101596.
  • [6] Haoyan Huang;Jie Ren;Guang-Hui Liu. Insights and Interventions in Age-Associated Inflammation.. Current opinion in genetics & development(IF=3.6). 2025. PMID:39837098. DOI: 10.1016/j.gde.2024.102306.
  • [7] L Duong;H G Radley;B Lee;D E Dye;F J Pixley;M D Grounds;D J Nelson;C Jackaman. Macrophage function in the elderly and impact on injury repair and cancer.. Immunity & ageing : I & A(IF=5.6). 2021. PMID:33441138. DOI: 10.1186/s12979-021-00215-2.
  • [8] Yumiko Oishi;Ichiro Manabe. Macrophages in age-related chronic inflammatory diseases.. NPJ aging and mechanisms of disease(IF=5.4). 2016. PMID:28721272. DOI: 10.1038/npjamd.2016.18.
  • [9] Jasna Gacic;Aleksandar Lazarov;Marijana Lazarov Bandic;Jadran Bandic;Srdjan Nikolovski;Marko Nikolic. Penile Skin as a Rare Location of Melanoma in the Balkan Region: A Case Report.. Acta medica portuguesa(IF=1.0). 2025. PMID:40018914. DOI: 10.20344/amp.22254.
  • [10] Weitao Zheng;Dechao Feng;Xingyu Xiong;Xinyang Liao;Sheng Wang;Hang Xu;Weizhen Le;Qiang Wei;Lu Yang. The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies.. Aging and disease(IF=6.9). 2023. PMID:37163421. DOI: 10.14336/AD.2023.0117.
  • [11] Ben Dugan;Jessica Conway;Niharika A Duggal. Inflammaging as a target for healthy ageing.. Age and ageing(IF=7.1). 2023. PMID:36735849. DOI: 10.1093/ageing/afac328.
  • [12] Mario García-Domínguez. Pathological and Inflammatory Consequences of Aging.. Biomolecules(IF=4.8). 2025. PMID:40149940. DOI: 10.3390/biom15030404.
  • [13] Yi Zhu;Jacqueline L Armstrong;Tamara Tchkonia;James L Kirkland. Cellular senescence and the senescent secretory phenotype in age-related chronic diseases.. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2014. PMID:24848532. DOI: 10.1097/MCO.0000000000000065.
  • [14] Adam Freund;Arturo V Orjalo;Pierre-Yves Desprez;Judith Campisi. Inflammatory networks during cellular senescence: causes and consequences.. Trends in molecular medicine(IF=13.8). 2010. PMID:20444648. DOI: 10.1016/j.molmed.2010.03.003.
  • [15] Hae Young Chung;Dae Hyun Kim;Eun Kyeong Lee;Ki Wung Chung;Sangwoon Chung;Bonggi Lee;Arnold Y Seo;Jae Heun Chung;Young Suk Jung;Eunok Im;Jaewon Lee;Nam Deuk Kim;Yeon Ja Choi;Dong Soon Im;Byung Pal Yu. Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept.. Aging and disease(IF=6.9). 2019. PMID:31011483. DOI: 10.14336/AD.2018.0324.
  • [16] Hee Tae Yu;Sungha Park;Eui-Cheol Shin;Won-Woo Lee. T cell senescence and cardiovascular diseases.. Clinical and experimental medicine(IF=3.5). 2016. PMID:26188489. DOI: 10.1007/s10238-015-0376-z.
  • [17] Slavko Mojsilović;Aleksandra Jauković;Tamara Kukolj;Hristina Obradović;Ivana Okić Đorđević;Anđelija Petrović;Diana Bugarski. Tumorigenic Aspects of MSC Senescence-Implication in Cancer Development and Therapy.. Journal of personalized medicine(IF=3.0). 2021. PMID:34834485. DOI: 10.3390/jpm11111133.
  • [18] Daniel Humphreys;Mohamed ElGhazaly;Teresa Frisan. Senescence and Host-Pathogen Interactions.. Cells(IF=5.2). 2020. PMID:32708331. DOI: 10.3390/cells9071747.
  • [19] Kseniia Matveeva;Mariia Vasilieva;Ekaterina Minskaia;Stanislav Rybtsov;Daniil Shevyrev. T-cell immunity against senescence: potential role and perspectives.. Frontiers in immunology(IF=5.9). 2024. PMID:38504990. DOI: 10.3389/fimmu.2024.1360109.
  • [20] Ashley Brauning;Michael Rae;Gina Zhu;Elena Fulton;Tesfahun Dessale Admasu;Alexandra Stolzing;Amit Sharma. Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions.. Cells(IF=5.2). 2022. PMID:35326467. DOI: 10.3390/cells11061017.
  • [21] Kyoo-A Lee;Rafael R Flores;In Hwa Jang;Ashley Saathoff;Paul D Robbins. Immune Senescence, Immunosenescence and Aging.. Frontiers in aging(IF=4.3). 2022. PMID:35821850. DOI: 10.3389/fragi.2022.900028.
  • [22] Stephan C Bischoff. Microbiota and aging.. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2016. PMID:26560527. DOI: 10.1097/MCO.0000000000000242.
  • [23] Paola Elizabeth Gámez-Macías;Elisa Félix-Soriano;Mirian Samblas;Neira Sáinz;María Jesús Moreno-Aliaga;Pedro González-Muniesa. Intestinal Permeability, Gut Inflammation, and Gut Immune System Response Are Linked to Aging-Related Changes in Gut Microbiota Composition: A Study in Female Mice.. The journals of gerontology. Series A, Biological sciences and medical sciences(IF=3.8). 2024. PMID:38364863. DOI: 10.1093/gerona/glae045.
  • [24] Anna Picca;Francesca Fanelli;Riccardo Calvani;Giuseppina Mulè;Vito Pesce;Alex Sisto;Cecilia Pantanelli;Roberto Bernabei;Francesco Landi;Emanuele Marzetti. Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia.. Mediators of inflammation(IF=4.2). 2018. PMID:29686533. DOI: 10.1155/2018/7026198.
  • [25] Despoina Gyriki;Christos G Nikolaidis;Eugenia Bezirtzoglou;Chrysa Voidarou;Elisavet Stavropoulou;Christina Tsigalou. The gut microbiota and aging: interactions, implications, and interventions.. Frontiers in aging(IF=4.3). 2025. PMID:40438731. DOI: 10.3389/fragi.2025.1452917.
  • [26] Cabirou M Shintouo;Tony Mets;David Beckwee;Ivan Bautmans;Stephen M Ghogomu;Jacob Souopgui;Lynn Leemans;Henry D Meriki;Rose Njemini. Is inflammageing influenced by the microbiota in the aged gut? A systematic review.. Experimental gerontology(IF=4.3). 2020. PMID:32882334. DOI: 10.1016/j.exger.2020.111079.
  • [27] Alexander M Vaiserman;Alexander K Koliada;Francesco Marotta. Gut microbiota: A player in aging and a target for anti-aging intervention.. Ageing research reviews(IF=12.4). 2017. PMID:28109835. DOI: 10.1016/j.arr.2017.01.001.
  • [28] Luca Liberale;Fabrizio Montecucco;Jean-Claude Tardif;Peter Libby;Giovanni G Camici. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease.. European heart journal(IF=35.6). 2020. PMID:32006431. DOI: 10.1093/eurheartj/ehz961.
  • [29] Byambaa Enkhmaa;Erdembileg Anuurad;Wei Zhang;Kyoungmi Kim;Lars Berglund. Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-Americans.. Atherosclerosis(IF=5.7). 2015. PMID:25710295. DOI: 10.1016/j.atherosclerosis.2015.02.023.
  • [30] Juan Francisco Aranda;Cristina M Ramírez;María Mittelbrunn. Inflammageing, a targetable pathway for preventing cardiovascular diseases.. Cardiovascular research(IF=13.3). 2025. PMID:39530590. DOI: 10.1093/cvr/cvae240.
  • [31] Maddalena Conte;Laura Petraglia;Paolo Poggio;Vincenza Valerio;Serena Cabaro;Pasquale Campana;Giuseppe Comentale;Emilio Attena;Vincenzo Russo;Emanuele Pilato;Pietro Formisano;Dario Leosco;Valentina Parisi. Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue.. Frontiers in medicine(IF=3.0). 2022. PMID:35242789. DOI: 10.3389/fmed.2022.844266.
  • [32] Hanamori F Skoblow;Christine M Proulx. C-Reactive Protein, Subjective Aging, and Incident Cardiovascular Disease: A Mediation Model.. The journals of gerontology. Series B, Psychological sciences and social sciences(IF=3.2). 2022. PMID:35279030. DOI: 10.1093/geronb/gbac051.
  • [33] Amir Ajoolabady;Domenico Pratico;Manlio Vinciguerra;Gregory Y H Lip;Claudio Franceschi;Jun Ren. Inflammaging: mechanisms and role in the cardiac and vasculature.. Trends in endocrinology and metabolism: TEM(IF=12.6). 2023. PMID:37076375. DOI: 10.1016/j.tem.2023.03.005.
  • [34] Luke Spray;Gavin Richardson;Judith Haendeler;Joachim Altschmied;Valencia Rumampouw;Sienna B Wallis;Georgios Georgiopoulos;Stephen White;Amanda Unsworth;Konstantinos Stellos;Simon Tual-Chalot;Ioakim Spyridopoulos. Cardiovascular inflammaging: Mechanisms, consequences, and therapeutic perspectives.. Cell reports. Medicine(IF=10.6). 2025. PMID:40782796. DOI: 10.1016/j.xcrm.2025.102264.
  • [35] Amsha S Alsegiani;Zahoor A Shah. The role of cofilin in age-related neuroinflammation.. Neural regeneration research(IF=6.7). 2020. PMID:31997804. DOI: 10.4103/1673-5374.274330.
  • [36] Alessia Piazza;Marina A Lynch. Neuroinflammatory changes increase the impact of stressors on neuronal function.. Biochemical Society transactions(IF=4.3). 2009. PMID:19143652. DOI: 10.1042/BST0370303.
  • [37] Edward Fielder;Clare Tweedy;Caroline Wilson;Fiona Oakley;Fiona E N LeBeau;João F Passos;Derek A Mann;Thomas von Zglinicki;Diana Jurk. Anti-inflammatory treatment rescues memory deficits during aging in nfkb1-/- mice.. Aging cell(IF=7.1). 2020. PMID:32915495. DOI: 10.1111/acel.13188.
  • [38] Erica Costantini;Chiara D'Angelo;Marcella Reale. The Role of Immunosenescence in Neurodegenerative Diseases.. Mediators of inflammation(IF=4.2). 2018. PMID:29706800. DOI: 10.1155/2018/6039171.
  • [39] Emmanuel Moyse;Slavica Krantic;Nesrine Djellouli;Sébastien Roger;Denis Angoulvant;Camille Debacq;Victoire Leroy;Bertrand Fougere;Amal Aidoud. Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases.. Frontiers in aging neuroscience(IF=4.5). 2022. PMID:35663580. DOI: 10.3389/fnagi.2022.827263.
  • [40] Katie Mayne;Jessica A White;Christopher E McMurran;Francisco J Rivera;Alerie G de la Fuente. Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?. Frontiers in aging neuroscience(IF=4.5). 2020. PMID:33173502. DOI: 10.3389/fnagi.2020.572090.
  • [41] Korbyn J V Dahlquist;Christina D Camell. Aging Leukocytes and the Inflammatory Microenvironment of the Adipose Tissue.. Diabetes(IF=7.5). 2022. PMID:34995348. DOI: 10.2337/dbi21-0013.
  • [42] Mita Varghese;Jianrui Song;Kanakadurga Singer. Age and Sex: Impact on adipose tissue metabolism and inflammation.. Mechanisms of ageing and development(IF=5.1). 2021. PMID:34474078. DOI: 10.1016/j.mad.2021.111563.
  • [43] Sylwia Dzięgielewska-Gęsiak;Małgorzata Muc-Wierzgoń. Inflammation and Oxidative Stress in Frailty and Metabolic Syndromes-Two Sides of the Same Coin.. Metabolites(IF=3.7). 2023. PMID:37110134. DOI: 10.3390/metabo13040475.
  • [44] Sarah J Shemtov;Rohini Emani;Olga Bielska;Anthony J Covarrubias;Eric Verdin;Julie K Andersen;Daniel A Winer. The intestinal immune system and gut barrier function in obesity and ageing.. The FEBS journal(IF=4.2). 2023. PMID:35727858. DOI: 10.1111/febs.16558.
  • [45] Daniela Frasca;Bonnie B Blomberg. Inflammaging decreases adaptive and innate immune responses in mice and humans.. Biogerontology(IF=4.1). 2016. PMID:25921609. DOI: 10.1007/s10522-015-9578-8.
  • [46] Martin Michaud;Laurent Balardy;Guillaume Moulis;Clement Gaudin;Caroline Peyrot;Bruno Vellas;Matteo Cesari;Fati Nourhashemi. Proinflammatory cytokines, aging, and age-related diseases.. Journal of the American Medical Directors Association(IF=3.8). 2013. PMID:23792036. DOI: .
  • [47] Philip C Calder;Nabil Bosco;Raphaëlle Bourdet-Sicard;Lucile Capuron;Nathalie Delzenne;Joel Doré;Claudio Franceschi;Markus J Lehtinen;Tobias Recker;Stefano Salvioli;Francesco Visioli. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition.. Ageing research reviews(IF=12.4). 2017. PMID:28899766. DOI: 10.1016/j.arr.2017.09.001.
  • [48] Gilyoung Lee;Geun-Shik Lee. Potential Role of Inflammasomes in Aging.. International journal of molecular sciences(IF=4.9). 2025. PMID:40725015. DOI: 10.3390/ijms26146768.
  • [49] Thibault Teissier;Eric Boulanger;Lynne S Cox. Interconnections between Inflammageing and Immunosenescence during Ageing.. Cells(IF=5.2). 2022. PMID:35159168. DOI: 10.3390/cells11030359.
  • [50] Emily L Goldberg;Vishwa Deep Dixit. Drivers of age-related inflammation and strategies for healthspan extension.. Immunological reviews(IF=8.3). 2015. PMID:25879284. DOI: 10.1111/imr.12295.
  • [51] Amit Singh;Shepherd H Schurman;Arsun Bektas;Mary Kaileh;Roshni Roy;David M Wilson;Ranjan Sen;Luigi Ferrucci. Aging and Inflammation.. Cold Spring Harbor perspectives in medicine(IF=10.1). 2024. PMID:38052484. DOI: 10.1101/cshperspect.a041197.
  • [52] Francesca Velotti;Roberta Bernini. Hydroxytyrosol Interference with Inflammaging via Modulation of Inflammation and Autophagy.. Nutrients(IF=5.0). 2023. PMID:37049611. DOI: 10.3390/nu15071774.
  • [53] Claudio Franceschi;Fabiola Olivieri;Alexey Moskalev;Mikhail Ivanchenko;Aurelia Santoro. Toward precision interventions and metrics of inflammaging.. Nature aging(IF=19.4). 2025. PMID:40813813. DOI: 10.1038/s43587-025-00938-7.
  • [54] Eicke Latz;Peter Duewell. NLRP3 inflammasome activation in inflammaging.. Seminars in immunology(IF=7.8). 2018. PMID:30268598. DOI: 10.1016/j.smim.2018.09.001.
  • [55] Bertrand Fougère;Eric Boulanger;Fati Nourhashémi;Sophie Guyonnet;Matteo Cesari. Chronic Inflammation: Accelerator of Biological Aging.. The journals of gerontology. Series A, Biological sciences and medical sciences(IF=3.8). 2017. PMID:28003373. DOI: 10.1093/gerona/glw240.
  • [56] Daniela Frasca;Bonnie B Blomberg. Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging.. Frontiers in immunology(IF=5.9). 2017. PMID:28894445. DOI: 10.3389/fimmu.2017.01003.
  • [57] Thomas W McDade. Three common assumptions about inflammation, aging, and health that are probably wrong.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 2023. PMID:38064531. DOI: 10.1073/pnas.2317232120.
  • [58] Luca Liberale;Lina Badimon;Fabrizio Montecucco;Thomas F Lüscher;Peter Libby;Giovanni G Camici. Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week.. Journal of the American College of Cardiology(IF=22.3). 2022. PMID:35210039. DOI: 10.1016/j.jacc.2021.12.017.
  • [59] Weiru Yu;Yifei Yu;Siyuan Sun;Chenxu Lu;Jianan Zhai;Yumei Lei;Feirong Bai;Ran Wang;Juan Chen. Immune Alterations with Aging: Mechanisms and Intervention Strategies.. Nutrients(IF=5.0). 2024. PMID:39599617. DOI: 10.3390/nu16223830.
  • [60] Michael G Flynn;Melissa M Markofski;Andres E Carrillo. Elevated Inflammatory Status and Increased Risk of Chronic Disease in Chronological Aging: Inflamm-aging or Inflamm-inactivity?. Aging and disease(IF=6.9). 2019. PMID:30705775. DOI: 10.14336/AD.2018.0326.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Aging · Inflammation · Cardiovascular Diseases · Neurodegenerative Disorders · Metabolic Syndromes

© 2025 MaltSci